Castillo, B., Appelbaum, J., Othus, M., Russell, K., Vyas, R., Hendrie, P., Halpern, A., Ghiuzeli, C. M., Cassaday, R., Mawad, R., Percival, M., Walter, R. (2025). Fractionated gemtuzumab ozogamicin (GO) with high-dose cytarabine (HiDAC) based induction chemotherapy is safe and highly effective for newly diagnosed favorable risk AML.. Blood. https://doi.org/10.1182/blood-2025-3378